STOCK TITAN

ADPT (NASDAQ: ADPT) insider plans 64,293-share sale under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of ADPT common stock has filed a notice of proposed sale under Rule 144 for 64,293 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an aggregate market value of 1,013,257.68. These shares were acquired on 01/12/2026 via a cash exercise of stock options from the issuer, with payment also made on that date.

The notice also lists prior Rule 10b5-1 sales for Francis Lo over the past three months, including a sale of 113,890 common shares on 12/15/2025 for gross proceeds of 1,773,381.19, along with additional smaller sales on 12/22/2025 and 01/02/2026. By signing, the seller represents not knowing any undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ADPT shares are covered by this Form 144 notice?

The Form 144 notice covers a proposed sale of 64,293 shares of ADPT common stock, with an aggregate market value of 1,013,257.68.

How were the ADPT shares in this Form 144 acquired?

The 64,293 ADPT common shares were acquired on 01/12/2026 through a cash exercise of stock options from the issuer, with payment made the same day.

Which broker is handling the planned ADPT share sale?

The planned sale of 64,293 ADPT common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, listed at 1 New York Plaza, New York, NY 10004.

On which exchange are the ADPT shares expected to be sold?

The notice states that the 64,293 ADPT common shares are expected to be sold on the NASDAQ exchange.

What prior ADPT stock sales by the same seller are disclosed?

Over the past three months, disclosed Rule 10b5-1 sales for Francis Lo include 113,890 common shares sold on 12/15/2025 for 1,773,381.19, plus additional sales of 4,394 shares on 12/22/2025 and 3,125 shares on 01/02/2026.

What representation does the seller make in this ADPT Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Adaptive Biotechnologies

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.71B
149.06M
2.34%
97.89%
5.54%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SEATTLE